Pigmentary disorders


Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligo affecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites


    Related Conference of Pigmentary disorders

    November 17-18, 2025

    8th International Dermatology Conference: Skin and Body

    Paris, France
    February 05-06, 2026

    9th Annual Conference on Skin Cancer and Dermatology

    Paris, France
    April 16-17, 2026

    9th World Cosmetic and Dermatology Congress

    Paris, France
    June 15-16, 2026

    COSMETIC DERMATOLOGY 2026

    Paris, France
    June 22-23, 2026

    28th World Dermatology and Aesthetic Congress

    London, UK
    August 25-26, 2026

    26th European Dermatology Congress

    Paris, France

    Pigmentary disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in